Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2024

  1. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2020

  1. CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 11

  2. Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 521-530